fashion -WSS

fashion

author：comprehensive 2025-10-01 01:51:25 - browse：2

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Trump got a 'target letter.' What is one and what does it mean?

Wikipedia

WSS

Supreme Court wrestles with OxyContin maker's bankruptcy deal

How dance can help health care workers heal from trauma

The woman behind the Dana Farber

Spinal cord stimulation reduces pain in amputees, study finds

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Supreme Court wrestles with OxyContin maker's bankruptcy deal

focus

fashion

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

The kidney, in all its complexity, is captured in a new atlas

After affirmative action ruling, medical educators look to 'holistic review'

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In diabetes hearing, Sanders takes on a new foe: food makers

Medical leaders decry Supreme Court decision on affirmative action

Couple fighting to bring baby home from Mexico are finally reunited

Peter Hotez and the public health issue of online harassment

Chemotherapy shortages won’t get better under Biden’s latest plan

entertainment

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Pregnancy discrimination could be enabled by AI

Teach medical students about patients with intellectual disabilities

TikTok cracks down on users posting about weight loss drugs

Supreme Court wrestles with OxyContin maker's bankruptcy deal

New warning issued for rebooking air travel after delays, cancellations

knowledge

Wikipedia

focus

knowledge